For instance, the activation of the insulin-like growth factor 1 receptor (IGF1R) in HCC cells increases GPX4 levels, and creatine kinase B (CKB) phosphorylates GPX4 to inhibit its degradation, thereby inhibiting ferroptosis and facilitating tumorigenesis [49]. Here, GPX4 is linked to hepatocellular carcinoma.